Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Updates On Covid-19 Effect On Xvivo Perfusion

March 18 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * THE COVID-19 EFFECT ON XVIVO PERFUSION
    * XVIVO PERFUSION SEES A DECLINE IN DEMAND FOR TRANSPLANT
PRODUCTS
DUE TO COVID-19 EPIDEMIC FOR AT LEAST NEXT QUARTER BUT SEES NO
LONG-TERM IMPACT ON DEMAND
    * PLANNED START OF CLINICAL TRIALS IN EUROPE HAS BEEN
DELAYED
    * AN ACTION PROGRAM IS NOW BEING IMPLEMENTED TO REDUCE
EXPENDITURE
    * COMPANY ESTIMATES THAT SALES DURING Q1 WILL BE
APPROXIMATELY 15
PERCENT LESS THAN LAST YEAR

Source text for Eikon:  ID:nWkr7MZYPm 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Xvivo Perfusion AB

See all news